Receipt of targeted therapy and survival outcomes in patients with metastatic colorectal cancer
SM Koroukian, BD Booker, L Vu… - JAMA Network …, 2023 - jamanetwork.com
Importance Professional society guidelines recommend treating patients with metastatic
colorectal cancer with targeted therapies, including epithelial growth factor receptor (EGFR) …
colorectal cancer with targeted therapies, including epithelial growth factor receptor (EGFR) …
Application of pharmacoepidemiological approaches to generate real-world evidence on the use and impact of metastatic colorectal cancer medicines
HMA Yasin - 2023 - stax.strath.ac.uk
Introduction: Metastatic colorectal cancer (mCRC) is characterised by multiple treatment
strategies. Randomised clinical trials are not always aligned with clinical practice, and …
strategies. Randomised clinical trials are not always aligned with clinical practice, and …
Razlika preživljenja bez znakova progresije bolesti i ukupnog preživljenja lijevostranog i desnostranog metastatskog kolorektalnog raka kod divljeg tipa RAS …
V Pavlović - 2024 - zir.nsk.hr
Sažetak CILJEVI ISTRAŽIVANJA: Ispitati vrijeme do progresije bolesti kod bolesnika RAS-
WT metastatskog kolorektalnog raka liječenih u prvoj liniji kemoterapije sa anti-VEGF …
WT metastatskog kolorektalnog raka liječenih u prvoj liniji kemoterapije sa anti-VEGF …
[PDF][PDF] Bioscience Research
NM Allam, MK Mohamed, HF Zahran, MH El Sheikh… - 2019 - researchgate.net
expression, but were lower than those recorded for acute infections. However, the fold
increase was higher for IL-8 and IL-10 than those recorded for IL-4 and IL-6, calculated …
increase was higher for IL-8 and IL-10 than those recorded for IL-4 and IL-6, calculated …